Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.
about
Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditionsDevelopment of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designDevelopment of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 2(3) full-factorial design.Cavamax W7 composite psoralen ethosomal gel versus cavamax W7 psoralen solid complex gel for topical delivery: A comparative evaluationFormulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designDevelopment and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design.Statins therapy: a review on conventional and novel formulation approaches.Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems.Cellulose Acetate 398-10 Asymmetric Membrane Capsules for Osmotically Regulated Delivery of Acyclovir.Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.Topical delivery of paclitaxel for treatment of skin cancer.Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release.Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design.Developing micro-/nanoparticulate drug delivery systems using "design of experiments".A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation.Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 23 full-factorial design and in vivo determination of GABA neurotransmitter.Topical phenytoin nanostructured lipid carriers: design and development.Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.Factorial Design Studies and Biopharmaceutical Evaluation of Simvastatin Loaded Solid Lipid Nanoparticles for Improving the Oral BioavailabilityOptimization of Bi2O3, TiO2, and Sb2O3 doped ZnO-based low-voltage varistor ceramic to maximize nonlinear electrical properties
P2860
Q28482479-5C2B1F77-BE35-4713-ADE1-9111C171E20DQ34160297-1739E3F7-AEB5-4B57-BE9D-1128DD9601A5Q34883416-4E83E9D7-AA11-47C1-A7C5-896E056723B7Q34977425-6047A9EA-4405-4F15-9E2C-49FE4105CCC3Q35071238-A6B028BC-6FBB-4877-B643-2A9C1212D826Q35796474-4751F49F-405A-41EF-9A04-778352F21212Q37330760-06616E16-6BFB-4EF6-B93B-BC0F2C293A61Q37896125-C4935DBE-645F-4A3F-A441-2F34B6B28B51Q38572098-7E9214CB-070E-4376-B225-B5706672E741Q38621553-D8A12F56-D2F8-41C7-9FD4-097190C11F17Q39810160-8486B926-12CD-4161-91B0-7F6C26C69254Q40019226-4295AB18-D617-4096-ACE0-876971B3FBFCQ41909406-4330D85C-A3E9-44DF-AE49-3D0C07872B0CQ42087508-B497C7DA-DC0C-4A13-A0A2-194CD71D6955Q42098613-A8724AAE-4FA0-498F-91FE-A9162EDDF3E6Q42227130-C973A881-A399-4A80-98AD-06BA86573F53Q42708749-ECE25DCB-C6FF-4E59-9031-72F788A00D83Q42827034-4BD365EB-C0C8-4806-BA00-33638B844B2DQ44688209-5348D012-4E70-4354-8291-09CFE6BFFBDAQ47918290-CB923702-1931-4642-84C4-5E2020286A3DQ47925556-A508B3DD-B0BE-4C19-BF12-11EFDCE0C996Q47931787-F4331A28-A72F-4979-B29B-870CB14CE8FDQ52092764-45B690F2-0F42-458A-A5FC-4241C613A2C6Q53542373-60827149-B812-4ECD-88D9-64C7AE9FCAFCQ59049929-75201961-47C1-4DA8-A699-EF2B64D2DD1AQ59100665-21FF535B-9E19-4C42-9984-7B6307B138F5
P2860
Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development and statistical op ...... ng 2(3) full-factorial design.
@ast
Development and statistical op ...... ng 2(3) full-factorial design.
@en
type
label
Development and statistical op ...... ng 2(3) full-factorial design.
@ast
Development and statistical op ...... ng 2(3) full-factorial design.
@en
prefLabel
Development and statistical op ...... ng 2(3) full-factorial design.
@ast
Development and statistical op ...... ng 2(3) full-factorial design.
@en
P2860
P1433
P1476
Development and statistical op ...... ng 2(3) full-factorial design.
@en
P2093
Kamla Pathak
Mayank Shah
P2860
P2888
P304
P356
10.1208/S12249-010-9414-Z
P407
P577
2010-03-23T00:00:00Z
P5875
P6179
1046838741